布里瓦拉塞坦:在中药理学,临床有效性和安全性
1Department of Neurology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
Journal of epilepsy research
|June 26, 2025
概括
布里瓦拉是一种突触囊泡2A (SV2A) 连接体,有效降低焦点发作发作中的发作频率. 它提供了有利的安全性和良好的耐受性,使其成为一种有价值的治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 临床医学 临床医学
背景情况:
- 布里瓦拉是一种针对突触囊泡2A (SV2A) 的新型抗发作药物.
- 它已被批准用于焦点发作的发作,作为各种年龄组的辅助或单一治疗.
研究的目的:
- 审查和综合临床试验和关于布里瓦拉塞坦的现实世界的数据.
- 评估布里瓦拉对发作管理的疗效,安全性和耐受性.
主要方法:
- 临床试验的系统审查.
- 对现实世界的证据研究进行分析.
主要成果:
- 布里瓦拉证明了强大的发作控制,显著减少了发作频率和高反应率.
- 有利的药理动力学特性和选择性SV2A结合有助于其疗效.
- 观察到良好的耐受性和安全性,包括在特殊人群中,如老年人和中风后患者.
结论:
- 布里瓦拉是一种有价值的治疗选择,具有独特的药理性质.
- 它解决了管理方面的未满足需求,对更广泛的患者群体显示出希望.
- 建议进行进一步的研究,以探索长期的安全性和扩大治疗应用.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
461
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
461
Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289
Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681
Antiepileptic Drugs: Glutamate Antagonists
527
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
527
Antiepileptic Drugs: Sodium Channel Blockers
950
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
950


